Regenerative Medicine aims to treat and cure certain diseases from the patient's own biological material. BTI has developed the regenerative technology PRGF – ENDORET® to perform personalized treatments in different pathologies from different therapeutic areas.
BTI is considered a worldwide scientific reference in regenerative medicine. This recognition is the result of the successful use of PRGF – ENDORET® in different medical specialties such as dentistry, traumatology, dermatology, ophthalmology, sports medicine, vascular surgery, aesthetics, reproductive medicine, among others.
PRGF – ENDORET® is a biomedical technology through which we are able to stimulate tissue regeneration by concentrating growth factors and other proteins that are found in the patient's very own blood plasma.
The therapeutic application of PRGF – ENDORET® in orthopedic surgery and sports medicine has been revealed as one of the most effective treatments for osteoarthritis, tendon, ligament and muscle injuries, as well as in the recovery of fractures and surgical interventions.
The set of PRGF – ENDORET® technology formulations represent a solution in terms of safety, efficacy and reproducibility that ophthalmologists demanded in the treatment of various ocular pathologies.
Plasma rich in growth factors in aesthetic medicine is used to encourage skin rejuvenation and to mitigate mild and moderate wrinkles.
The use of PRGF – ENDORET® for endometrial conditioning or for the treatment of low ovarian reserve can open up new avenues for fertility recovery.The growth factors of PRGF – ENDORET® contribute to increased vascularization, decreased inflammation, and reduced fibrosis.
Additionally, the use of plasma rich in growth factors can aid in the regeneration of ovarian follicles.
The different liquid plasma rich in growth factors formulations used in dermatology favour the regeneration of dermal tissue and improve the quality and health of skin.
